E_N_T_R_O_P_Y: Monocentric analysis of rectal cancer radio-chemotherapy treatment in patients of young age
Elderly patients have a prevalence of advanced disease. Younger patients seem having a better OS at 3 and 5 years. ESMO risk group and age were the only variables affecting OS and DFS. Young patients have better MFS and DFS at 2 and 5 years than patients older than 55 years. The addition of oxaliplatin to fluoropyrimidine-based neoadjuvant chemotherapy resulted not significant in both groups.
Authors
- Claudio Coco (ORCID: https://orcid.org/0000-0002-4713-7093)
- B. Corvari
- Fabio Pacelli
- M. Gambacorta (ORCID: https://orcid.org/0000-0002-9035-3517)
- Roberta Menghi (ORCID: https://orcid.org/0000-0002-8088-0807)
- A. Nicolì (ORCID: https://orcid.org/0009-0002-8296-3275)
- E. Meldolesi
- G. Chiloiro
- N. Dinapoli
- A. Romano
- S. Manfrida
- Carlo Ratto (ORCID: https://orcid.org/0000-0002-0556-0037)
- Roberto Persiani (ORCID: https://orcid.org/0000-0001-5584-6095)
- L. Boldrini
Institutions
- Agostino Gemelli University Polyclinic (IT)
- Accademia di Belle Arti di Lecce (IT)
- Istituto Nazionale di Fisica Nucleare, Sezione di Lecce (IT)
- Fatebenefratelli Hospital (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
Publication Details
- Journal
- Clinical and Translational Radiation Oncology
- Published
- 2024-12-29
- DOI
- https://doi.org/10.1016/j.ctro.2024.100905
- Primary Topic
- Colorectal Cancer Surgical Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00